Proposed updates to label draw praise from public health groups, concern from food industry.
TTB withholds “gluten-free” label for specially processed beers.
The FDA’s gluten-free labeling rule may lead manufacturers to inform some consumers while misleading others.
FDA adjusts maximum civil money penalties to account for inflation.
FDA declares personalized medicine “has clearly arrived.”
Scholar proposes a manufacturers’ excise tax to fund obesity-prevention efforts.
New agency rule designed to help identify faulty medical devices.
Plan B episode calls for reconsidering the scope of judicial review and the role of politics in rulemaking.
FDA seeks comment on its determination trans fats are unsafe and should be banned.
Agency hopes a strategic plan and proposed rule will protect patients from delayed treatment.